Pre-Exam 2024 - our answers to the legal questions (part 1 & part 2)

As the earlier Pre-Exams since 2021, this online EQE Pre-Exam was again held in four parts of 70 minutes each. The questions had to be taken, almost fully, from the screen (only the description of the application and the prior-art documents in the claims analysis parts were printable; also no calendars were provided).

Our answers to the legal part are given below. We have numbered the questions and statements for easy reference in the discussion.

During the exam, candidates had access to the EPO Legal Text pages, so including the full EPC Articles and Rules, Guidelines, GL/PCT-EPO, National Law Tables, Case Law, and the Euro-PCT Guide (HTML versions), as well as to some of the PCT Legal Texts, esp. PAT Articles and Rules and the PCT Applicant’s Guide in the new eGuide format (as on www.wipo.int/pct/en). Access to the EPO text was to the live versions, so to the versions in force on 15 March 2024 (so not the version of 31.10.2023 acc REE/IPEE). The PCT texts were in the version in force on 31 October 2023.

Candidates could access the exam in all languages, English, French and German: the language of the question could be selected. All statements were given in all three languages. 

In the legal as well as the claims analysis parts, the order of the four statements of each of the questions was randomized, i.e., it was different for different candidates.

Also the order of the questions was randomized in the legal parts (e.g., the sequence shown below was presented to one candidate, while another candidate reported getting what is shown below as Q.2 as the first question,), but not in the claims analysis parts.

In view of the randomized order, we provide the questions and statement together with our answers. If you check your answers with ours, note that the order of the questions and of the four statements from a single question may be different!!!

This year’s exam reused quite some questions from earlier Pre-Exams, with essentially just names of persons and dates adapted. Well-prepared candidates that practiced all old exams from the Compendium, including the 2019 and 2022 Pre-Exam in the Wiseflow EQE Compendium, or the updated versions thereof from our P-book will presumably have appreciated this approach. See our comments with the questions

Please feel invited to comment!

Please do not post your comments anonymously - it is allowed, but it makes responding more difficult and rather clumsy ("Dear Mr/Mrs/Ms Anonymous of 15-03-2024 20:23"), whereas using your real name or a nickname is more personal, more interesting and makes a more attractive conversation. You do not need to log in or make an account - it is OK to just put your (nick) name at the end of your post.

You may also want to check the other blogs: first impressions and claims analysis (part 3 & part 4)

Diane & Roel

 

Part 1

Question 1

Zlatko filed a European patent application EP-Z in Croatian as a first filing with the European Patent Office on 16 March 2023. EP-Z does not contain any claims.

For each of the statements, indicate whether the statement is true (T) or false (F):

1.1 The period for filing an international patent application validly claiming priority from EP-Z ends on 16 March 2024.

FALSE  - 16/3/23 + 12m -> 16/3/24 (Sat) [R.134(1)] --> 18/3/24              

1.2 The period for filing claims for EP-Z ended on 16 May 2023.

FALSE - no particular time limit for submitting claims of own volition; ultimate period is within 2m from invitation under R. 58 EPC                       

1.3 The period for filing a translation of EP-Z into one of the official languages of the EPO ended on 16 May 2023.

TRUE - 16/3/23 + 2 m  [R.6(1)] -> 16/5/24 (Thu)

FALSE could also be argued in view of R.58 and D 3/19. 

Update 9 April 2024: However, the Examiner's report (published today) provides that " if the translation is not filed in accordance with the period defined by Art. 14(2) and R. 6(1) EPC, there exists also a possibility to remedy a deficiency of filing the translation within the period, R. 57(a) and 58 EPC, GL A-VII 1.4; this period to remedy the deficiency is not the period for filing the translation;", so that the statement was not neutralized.                

1.4 The period for paying the filing fee for EP-Z ended on 17 April 2023.

TRUE- 16/3/23 + 1m [R.131(4)] -> 16/4/23 (Sun) [R.134(1)] -> 17/4/23 (Mon)

Note: that EP-Z contains no claims has no effect on the 1m period of R.38(1) to pay the (basic) filing fee. However, if the application comprises more than 35 pages, the additional fee referred to in R.38(2) ("page fee" which is part of the filing fee) shall be paid within 1m of filing the first set of claims.

              

 

Question 2

Daniel Automotive SE filed a European patent application EP-D in June 2020. Claus is designated as the sole inventor. Last week, Daniel Automotive SE received a communication under Rule 71(3) EPC for EP-D. On 15 March 2024, an error is noted: the inventors of EP-D are actually Claus and Sabrina. Daniel Automotive SE now consults you for advice.

A valid element of your advice for correcting the error before the EPO is that ...

For each of the statements, indicate whether the statement is true (T) or false (F):

 

2.1 … if the request is filed by Daniel Automotive SE, the consent of Claus is required to rectify the designation of the inventor.

FALSE  - GL A-III, 5.5                    

2.2 ... the designation of the inventor may be corrected after EP-D has been granted.

TRUE  - GL A-III, 5.5                     

2.3 ... the applicant need not provide evidence that an error was made.

TRUE  - only needs to be requested by the applicant, no provision for a fee

2.4 ... Sabrina may file an opposition based on the ground of not being mentioned as inventor.

FALSE  - no ground - exhaustive list of Art.100

Note: question reused from an earlier Pre-Exam                          

 

Question 3

Anna-Frieda filed a German national patent application DE-AF in German on 23 May 2022 disclosing a first invention AF1 and a second invention AF2. On 24 April 2023, Anna-Frieda filed a first European patent application EP-AF1 covering the invention AF1 only and claiming priority from DE-AF. On the same day, 24 April 2023, she also filed a second European patent application EP-AF2 covering the invention AF2 only and without claiming any priority. Afterwards, Anna-Frieda noticed that no drawings had been filed for EP-AF1 [R.56!!] and that the wrong claims had been erroneously filed [R.56a, not R.56, not R.58!!] for EP-AF2. On 2 May 2023, Anna-Frieda filed the missing drawings for EP-AF1, together with a certified copy of DE-AF, a letter correctly stating that the missing drawings are identical to those of DE-AF and a request to maintain the filing date of 24 April 2023. On 2 May 2023, Anna-Frieda submitted the correct claims for EP-AF2.

For each of the statements, indicate whether the statement is true (T) or false (F):

 

3.1 The period for making the declaration of priority from DE-AF for EP-AF2 ends on 26 August 2024.

FALSE  - 23/5/22 + 16m [R.52(2)] -> 23/9/2023 (Sat) -> 25/9/2023, not 2024                            

3.2 The filing date of EP-AF2 will be re-dated to 2 May 2023.

TRUE  - R.56a(3); – correct claims received within 2m so redated (priority not claimed at filing so not possible to use “incorporation by reference” to keep the date; was also not requested - R.56a(4))                  

3.3 The filing date of EP-AF1 will be re-dated to 2 May 2023.

FALSE  - R.56(3); as pri was claimed on filing and request to maintain date was duly filed with required documents                         

3.4 On 15 March 2024, Anna-Frieda can file a third EP patent application EP-AF3 validly claiming priority from EP-AF2 regarding the invention AF2.

FALSE  - DE-AF is first application for AF2, not EP-Af2, so priority invalid - Art 87(1)                    

 

Question 4

Manuela filed international application PCT-M in September 2021 without claiming priority. PCT M was searched by the EPO as International Searching Authority in February 2022. The International Searching Authority raised non-unity objections with respect to the subject-matter of the claims, considering claims 20 to 35 to relate to a separate invention with respect to claims 1 to 19. Manuela did not pay any additional fees. The International Searching Authority issued a partial search report covering claims 1 to 19. PCT-M entered the European phase on 15 March 2024 and is referred to in the following as Euro-PCT-M. No amendments have been filed.

For each of the statements, indicate whether the statement is true (T) or false (F):

 

4.1 If Manuela does not pay claims fees by expiry of the period set by Rule  161 EPC, Euro-PCT-M will be deemed to be withdrawn.

FALSE  - effect is " the claim concerned shall be deemed to be abandoned" - R.162(4)

Note: reference to R.161 period may appear incorrect, as it is R.162. But R.162 and 161 periods are the same; it is also a single invitation                         

4.2 Manuela will have an opportunity to amend the claims of Euro-PCT-M before substantive examination of Euro-PCT-M begins.

TRUE  - A response to the R 161(1) communication will be mandatory in view of non-unity objection by EPO as ISA. This may include amendments.. The R.161/162 invitation with a 6m time limit which will be issued after entry (entry is today).                  

4.3 If in the application documents which are to serve as the basis of the substantive examination of Euro-PCT-M an invention is claimed that was not searched by the EPO as the International Searching Authority, Manuela will be invited to pay a further search fee in respect of this invention.

TRUE  - R.164(2)(a)                       

4.4 If Manuela does not comment by 15 March 2024 on the written opinion of the International Searching Authority, Euro-PCT-M will be deemed to be withdrawn.

FALSE - R.161(1) allows 6m to comment and invitation not yet issued               

 

Question 5

Your client Pencilz has noticed that its biggest competitor Rulerz has a granted patent EP-R which covers important subject matter for Pencilz. The mention of the grant of EP-R was published in the European Patent Bulletin on 4 August 2023. Pencilz asked you to file an opposition against EP-R and the notice of opposition was filed on 15 February 2024. No opposition fee was paid. EP-R was opposed on the following grounds: added subject matter and lack of novelty. You also noticed some clarity issues with the granted claims of EP-R, which you also included in the statement of grounds filed with the notice of opposition.

For each of the statements, indicate whether the statement is true (T) or false (F):


5.1 On 15 March 2024, the opposition fee may still be paid.

TRUE - last day is 4/8/2023 + 9m -> 4/5/2024 [Sat) -> 6/5/2024, so can pay today (15/3/24)                          

5.2 Lack of clarity is a ground for opposition.

FALSE - not mentioned in Art 100                         

5.3 The Opposition Division may, of its own motion, examine EP-R for sufficiency of disclosure.

TRUE - GL D-V, 2.2, if prima facie (added: assuming that opposition proceedings become pending by payment of the opposition fee).

Added 2 April 2024 (in view of comments from Juliette and IT made below): FALSE can also be argued, as the opposition fee is not paid so that no admissible opposition is filed (yet), so that is no admissible opposition is filed and hence no own motion possibility (GL D-V, 2.2).

Added 12 April 2024: the "if prima facie" may also be a reason why a candidate to answered FALSE: the OD may only examine new grounds of own motion if they are prima facie relevant (GL D-V, 2.2), and as no facts are given in the question that support insufficiency, this requirement is not fulfilled and the OD may thus not introduce the new ground. 

However, 5.3 was not neutralized.               

5.4 A third-party that has filed observations with the EPO concerning the patentability of EP-R is party to the opposition proceedings.

FALSE - Art. 115                            

 

PART 2

Question 6

A European patent application is refused without holding oral proceedings for lack of novelty in a decision dated 1 February 2024. A request for oral proceedings filed by the applicant at an early stage in the examination procedure has been overlooked by the Examining Division. The applicant files an appeal with arguments explaining why the subject-matter claimed is novel over the prior art.

For each of the statements, indicate whether the statement is true (T) or false (F):


6.1 The statement setting out the grounds of appeal has to be filed within two months of filing the notice of appeal.

FALSE - 4m from notification of decision - Art.108                       

6.2 The appeal fee is to be reimbursed in full because the applicant's request for oral proceedings has been overlooked.

TRUE  - overlooking request for OP = subst proc violation and will result in interlocutory revision, Rule 103(1)(a), GL E-XII, 7.3 & (added 16/3:) GL E-XII, 7.4.1

Failure to hold oral proceedings violates applicant’s right to be heard and is a substantial procedural violation that may give rise to reimbursment of the appeal fee T93/88                      

6.3 If the notice of appeal does not contain the address of the appellant, and the address of the appellant is not given by today, 15 March 2024, the appeal will be rejected as inadmissible.

FALSE  - Requirement of R 99(1)a satisfied if appellant can be identified [T662/09]. EPO sent a decision to refuse to the applicant, so they know who the applicant is.'

Also still time, as notice period expires -Art.108:

1/2/2024 + 2m -> 1/4/2024 -> 2/4/2024 or 1/2/2024 + 10d + 2m -> 11/4/2024               

6.4 If the Examining Division considers the appeal to be admissible and well founded, it shall rectify its decision.

TRUE  - Art.109(1), GL E-XII,  7.1                           

 

Question 7

On 1 June 2021, Matthieu filed a European patent application EP-M1 disclosing and claiming a fork made of copper or zinc. No other materials are mentioned and the kind of handle is not specified. On 1 June 2022, Matthieu filed a European patent application EP-M2 claiming priority from EP-M1 and disclosing and claiming a fork made of metal. The description of EP-M2 mentions that the metal can be copper, zinc, iron or any alloy of these metals. Claim 1 of EP-M2 claims a fork made of metal, claim 2 of EP-M2 claims a fork made of metal with a hollow handle. EP-M1 was published on 1 December 2022 as EP-M1-A1. A company brochure PA-1 published on 5 October 2021 discloses a fork made of copper with a hollow handle.

For each of the statements, indicate whether the statement is true (T) or false (F):


7.1 EP-M1-A1 forms part of the state of the art against the subject-matter of claim 1 of EP-M2 under Article 54(3) EPC.

Problematic. Part of EP-M2 claim 1 is not entitled to priority, because broader than the  sjm not disclosed in EP-M1, while encompassing that, such that there is a partial priority situation - G 1/15, GL F-VI, 1.5

Then, the claim has to be treated as a "generic OR claim", by considering it an OR-claim of "a first conceptual part with priority" OR "a second conceptual part without priority".

I.e., claim 1 benefits from partial priority, EP-M1-A1 is NOT 54(3) vs the first conceptual part that benefits from partial priority (the conceptual part Cu or Zn), so the statement could be considered FALSE.

However, w.r.t. the second conceptual part that does not benefit from partial priority (the conceptual remainder, i.e. metal but not Cu nor Zn), EP-M1-A1 IS 54(3).

For the first conceptual part ("Cu or Zn"), the statement is FALSE. For the second conceptual part ("metal but not Cu nor Zn"), it is TRUE.  But how to combine that into a single TRUE or FALSE? One can (n)either conclude to TRUE (n)or to FALSE. We would consider this a candidate for neutralization.

(Note that EP-M1 is NOT novelty destroying for the claim, as it is not novelty destroying fort either part. However, that is not asked here!!!) 

Note (added 19/3 in view of discussions on the blog): the reference to the publication "EP-M1-A1 forms [...] 54(3)" is somewhat confusing: does it mean to indicate that the application was validly published, which is a prerequisite to be an Art.54(3) - which is our interpretation. Or is it intended to mean "the text of the A1 publication of EP-M1 is 54(3)" whereas it is the content of EP-M1 as filed that determines the prior art effect (even if that would be incomplete or gave errors - GL G-IV, 5.1). This may be another reason to consider neutralization.   

Update 9 April 2024: the Examiner's report (published today) shows that this statement was neutralized. The statement is numbered 7.2 in the Examiner's Report, which provides:

7.2 EP-M1-A1 forms part of the state of the art against the subject-matter of claim 1 of EP-M2 under Article 54(3) EPC.

TRUE and FALSE are accepted as correct answers – G1/15 GL F-VI, 1.5; claim 1 is only partially entitled to priority, i.e. for the part disclosed by EP-M1; for this disclosed part EP-M1-A1 does not form part of the state of the art according to Article 54(3) EPC (Article 89 EPC); EP-M1-A1 is not prior art according to Article 54(3) EPC for the subject-matter of claim 1 in its entirety;        

7.2 PA-1 forms part of the state of the art against EP-M2 under Article 54(3) EPC.

FALSE  - PA-1 is not an EP application so cannot be Art 54(3) prior art                

7.3 PA-1 is novelty-destroying for the subject-matter of claim 1 of EP-M2 under Article 54(2) EPC.

FALSE  - the conceptual Cu part benefits from partial priority and is thus not novelty destroyed.

PA-1 is 54(2) prior art for remaining part of claim 1 not entitled to priority, but that part relates to metals other than Cu or Zn, so not novelty destroyed by disclosure of Cu fork.

As both conceptual parts novel, claim as a whole novel.                         

7.4 PA-1 is novelty-destroying for the subject-matter of claim 2 of EP-M2 under Article 54(2) EPC.

TRUE  - the metal plus handle has no partial, nor full priority. Destroyed by Cu plus handle.              

 

Question 8

On 28 February 2024, Martha, a Polish national resident in Poland, filed with the EPO a reasoned notice of opposition against European patent EP-E in Polish. The mention of the grant of EP-E was published in the European Patent Bulletin on 16 June 2023. The language of the proceedings in the case of EP-E is English. In the notice of opposition, Martha requested oral proceedings.

For each of the statements, indicate whether the statement is true (T) or false (F):

 

8.1 Martha must file the translation of the notice of opposition at the latest on 18 March 2024.

FALSE  - Rule 6(2): latest of

- 28/2/24 + 1m -> 28/3/24 and

- 16/6/23 + 9m -> 16/3/24 (Sat) -> 18.3.24 (Mon),

so 28/3/24.                      

8.2 Martha is not entitled to a reduction of the opposition fee.

TRUE - no such reductions (only until 2014) 

Note: I was told by an expert in exam design that it is a general guidance that negative statements are to be prevented in multiple-choice exams, in view of the high risk that a candidates has the correct understanding and applies it correctly to the facts of the case, concludes "not" entitled, and hence logically answers FALSE, and thus comes with the wrong answer just because of the negative in the statement.                 

8.3 If Martha requested in the notice of opposition to speak and listen in German during oral proceedings, the EPO would provide for interpretation.

TRUE - R.4(1), first sentence, first alternative: German is an official EPO language [Art 14(1)] and may be used instead of language of proceedings [R. 4(1)]. Request to use German received well in advance of 1m before the oral hearing, so EPO responsible for interpretation at EPO's own expense.                 

8.4 Martha will be allowed to speak Polish during oral proceedings if she provides for interpretation into English.

TRUE - R.4(1) second sentence

Question reused from an earlier Pre-Exam (Q.10 of Pre-Exam 2016, with names, language, states changed - see also our book "Pre-Exam - Cases/Exams")                   

 

 

Question 9

Sara, an Italian citizen living in Italy, filed an international application PCT-S1 in French with the EPO on 20 September 2021 without claiming priority. PCT-S1 documents as filed are: PCT request form designating all PCT contracting states, description, claims, drawings and abstract. After filing, Sara noticed that her name was misspelt on the PCT request form, but she could still be identified.

For each of the statements, indicate whether the statement is true (T) or false (F):

 

9.1 Further processing for performing the requirements for entry into the EP regional phase can be validly requested on 19 June 2024.

TRUE - 20/9/21 + 31m -> 20/4/24 [Sat) -> 22/4/24.

If missed, earliest possible loss of rights communication is 23/4/24:

23/4/24 + 2m -> 23/6/24, or 23/4/24 + 10d + 2m -> 2/5/24 + 2m -> 2/7/24.

So can surely do on 19/6/24            

Note (added 17/3): one could also argue TRUE as the missed renewal fee (due on entry in this case) under Rule 159(1)(f)) cannot be remedied with further processing, but needs Rule 51(2). Whether one answers TRUE or FALSE may thus depend on whether one considers the statement to refer to all requirements for entry, or to those for which missing the entry causes a loss of rights (R.160(1)) at the 31m expiry. We decided for TRUE as we considered the latter seemed to us the interpretation that was most likely expected, as there is no loss yet due to non-payment of the renewal by the due date: that loss only occurs at the expiry of the 6m period of R.51(2) (22/4/24 + 6m -> 22/10/24 (Tue)); this is also reflected in the loss-of-rights communication that the EPO sends shortly after missing the 31m period: renewal is not mentioned therein. One would also interpret the statement as merely testing the situation on 19 June 2024, i.e., whether FP is still available then - that would also result in TRUE. 

Update 9 April 2024: The Examiner's report (published today) makes no mention of the missed renewal fee, and hence argues TRUE.

9.2 20 September 2021 is the international filing date of PCT-S1.

TRUE - all requirements of Art. 11 (1)PCT fulfilled.

Also, if the answer would be FALSE, you cannot answer any of the other three statements.                     

9.3 An extension of the time limit for performing the requirements for entry into the EP regional phase can be validly requested on 20 February 2024.

FALSE - not possible for the 31m period. 31m specified in EPC so not under R.132(2); no other provisions either.                             

9.4 Without resorting to a legal remedy, the acts for entry into the EP regional phase shall be performed at the latest on 20 March 2024.

FALSE - 20/9/21 + 31m -> 20/4/24 (Sat) [R.134(1)] -> 22/4/24. You would have wrongly answered TRUE if you wrongly used 30m or if  you did not check the calendar/ dis not use R.134(1).

              

Question 10

Wolfgang intends to file the following patent applications:

(1) a European patent application EP-W;

(2) an international patent application PCT-WC.

PCT-WC will be jointly filed in the name of Wolfgang and Christina.

Christina lives in Berlin; Wolfgang lives in Uruguay and is of Uruguayan nationality. Uruguay is not a PCT member state.

For each of the statements, indicate whether the statement is true (T) or false (F):

 

10.1 PCT-WC may be validly filed with the EPO as receiving Office.

TRUE - Christina lives in Germany which is a PCT state and an EPO contracting state, so EPO is a competent receiving office. R 19.1(a) PCT; R. 157(1) EPC.

Sufficient if 1 applicant has an entitlement to file a PCT - Aret. 9(1);'R.19.2(ii) PCT

PCT-WC must be filed in English, French or German for the EPO to act as rO. R.12.1 PCT; R.157(2) EPC                   

10.2 If Wolfgang moves to Berlin two months after validly filing PCT-WC, the International Bureau will, upon request, record the change of residence in relation to PCT-WC.

TRUE - Rule 92bis PCT; AG-IP 11.018-11.022: the IB will record a change under R.92bis at any time before 30m international phase ends.

Note that the earlier version of this question (in Pre_Exam 2019, said "the EPO will record the change" - and that is FALSE)                            

10.3 PCT-WC can be validly filed with the International Bureau as receiving Office.

TRUE - Christina lives in Berlin. True, IB is a competent rO for any applicant from any PCT contracting state                          

10.4 Wolfgang may validly file EP-W with the EPO.

TRUE - anyone may file an EP application Art 58 EPC

Question from Pre-Exam 2019 reused for the second time )with statement 3 changed from EPO to IB) - also last year (when EPO was maintained). 

 

Please feel invited to comment!

When commenting, please do not post your comments anonymously - it is allowed, but it makes responding more difficult and rather clumsy ("Dear Mr/Mrs/Ms Anonymous of 15-03-2024 23:22"), whereas using your real name, your initial or a nickname is more personal, more interesting and makes a more attractive conversation. You do not need to log in, not make an account, nor give your email address; you can us post Comment As --> Name or URL: Give your name, nickname or your initials and use them consistently.

 

Diane & Roel

(c) DeltaPatents

Comments

  1. Question 3.2: why is there a redating? why the claims filed later would no be considered as an amendment?

    ReplyDelete
    Replies
    1. Dstinguish missing claims (No R.56, but R.58) vs erroneous claims (R.56a).

      Delete
    2. Hi Armando, the EPC was updated in Nov 2022 via new Rule 56a to cover situations where "erroneously filed" application documents are submitted, e.g. a wrong set of claims. Before then, only missing parts could be added into an EP application. But the principles are, broadly speaking, the same: if you add something new after filing date has been accorded, (within applicable 2m time limit) then the application is re-dated to the date of receipt of the e.g. replacement claims. See R. 56a(3).

      Delete
    3. How are you able to get in the situation of Rule 56a(2), in the sense of filing correct parts before (the date of) filing the erroneous parts?

      Delete
    4. Not the case in this Q. But also not was 56a(2) says: it says corrected docs before or on the filing date - see Guidelines https://www.epo.org/en/legal/guidelines-epc/2024/a_ii_6_6.html

      Delete
    5. @Diane Admittedly, I had trouble deciphering the meaning of the expression "wrong claims had been erroneously filed", as recited by the question.

      "wrong claims" ought to be interpreted as claims that were not intended to be subject for a search. Meaning, I reasoned that other claims ought to have been filed instead of the present claim set.

      Firstly, please correct me if I am wrong, but how does the EPO know that one has actually filed the wrong set of claims, and is actually not abusing the system in order to maintain an early date of filing? In other words, I could in principle just file a set of random claims in order to acquire a date of filing, whereafter I could just state to the EPO that those were the wrong claims?

      Secondly, notwithstanding the above item, you cite "if you add something new after filing date has been accorded, (within applicable 2m time limit) then the application is re-dated to the date of receipt of the e.g. replacement claims. See R. 56a(3)".

      Anna-Frieda submitted the correct claims for EP-AF2 but how can we be sure that the correct claims do not contain new subject-matter? What is actually to be assumed in this question?

      Delete
    6. It uses the wording of the provision, Rule 56a (newly introduced per 1 Nov 2022, when also Rule 56 was amended), so not in printed materiel tbat is not up-to-date to that date. Also in detail in the Guidelines.

      If you use Rule 56a(4) they “know” it is wrong as you wanted to file the same as in the priority - that is why the requirements of Rule 56a(4) are so strict.

      Delete
    7. See Guidelines A-II, 6 “Correction of erroneously filed application documents or parts” and subsections for Rule 56a

      Delete
  2. Thank you for the answers! I have two comments:

    Question 1.4: You say it's false it ended on 17 April, but you calculate the date 17 April in the reasoning. I assume that's an error and should say true?

    Question 6.2: You state that it's true the appeals fee is reimbursed. However, my reading of the Guidelines and Art. 103(1)(a) is that it's only reimbursed if there was a substantial procedural error (true) and an interlocutory revision based solely on the procedural error (which we don't know - we only know the appeal was filed, they could decide that the invention is not novel anyway). So the statement that it is to be reimbursed should be false, since it only might be reimbursed depending on the outcome.

    ReplyDelete
    Replies
    1. 1.4: oops, we argued True but accidentally put False as an answer. Now corrected. Thanks!

      Delete
    2. i thought the same as you, but i found that this would be too deep and i marked TRUE

      Delete
    3. Q 6.2: Hi Johanna, I tend agree with you. A substantial procedural violation has occurred, but we don't know yet whether the appeal is allowable or interlocutory revision will occur, so cannot state with certainty that appeal fee will be reimbursed in full under R 103(1)a

      Delete
    4. Q 6.2 Diane, I agree with your reasoning. Could further be argued, that in the appeal the applicant doesn't mention that the oral proceedings weren't held, therefore the Examining Division needn't account for that procedural violation in their decision?

      Delete
    5. @Klaus Q 6.2: I put false exactly because of this reasoning

      Delete
    6. @Roel In the GL example, the letter of appeal only states the grounds that oral proceedings were not held. In this case, the only thing we know about the letter of appeal is that it contains arguments for novelty. It's not even given in the question that the letter also mentions the lack of oral proceedings as a grounds.

      Delete
    7. As I understand it, this question refers to the full reimbursement of the appeal fee in the event of an interlocutory revision. This takes place if the applicant overcomes the grounds for refusal (by filing the appeal with convincing arguments on novelty).

      However, the statement says that the appeal fee is reimbursed in full BECAUSE the request for oral proceedings was overlooked.

      This is F because it would mean that a interlocutory revision is made because of something that the applicant did not even request.

      Delete
    8. When the division will get the appeal (before it goes to the Boards), they will check why there is now a novelty argument while they refused as to lack of novelty. They will then see that the revise for OP was overlooked, and grant interlocutory revision based on (just) the latter: possible the reopening is immediately oral proceedings before the division. So, interloc revision due to overlook of request for OP = subst proc viol, so few refunded full. In the event the division would not grant interloc revision, the Board will have the same reasoning and remit as novelty as never discusses in first instance.

      Delete
  3. Question 1.4: Shouldnt the answer be true? (17/4 vs 17/4)?

    ReplyDelete
    Replies
    1. See above. Frequently made mistake: reasoning that something is True, but nevertheless putting False down as an answers. Highest risk in "not"-statements ("The claim is not novel").

      Delete
  4. Do you know when the results come up?

    ReplyDelete
    Replies
    1. No, but when you look to the history by checking the blogs of previous years, you will see that is usually takes 3 weeks or so, but last year it took much much longer.

      Delete
    2. There was an official notice saying - Results would be out till July.

      Delete
    3. July, that's ridiculous. Do you have the link to the notice? I could not find it.

      Delete
    4. https://acrobat.adobe.com/id/urn:aaid:sc:EU:f66aeefc-59bc-4c2d-85e0-8ac58f7d6a02

      Communication from the Examination Board for the European Qualifying Examination with regards to the EQE 2024- In connection with the Unitary Patent and the Unified Patent Court, particularly in reference to representation under Article 48(2) of the Agreement on a Unified Patent Court, the Examination Board hereby formally notifies all concerned parties that the results of the EQE 2024 will be available in July 2024

      Delete
    5. The relevance of that Notice is for main exam candidates: they could possibly benefit from a UPC grandfather clause until 1 year after entry into force of the UPCA (so until 31/5/2024). The Notice clarifies that the results will not be available in time for that.

      There is no reason to assume that Pre-Exam results will be as late, nor later than usual:
      2023 - Pre-Exam 17 March - results 11 May (later than earlier years);
      2022 - Pre-Exam 18 March - results 8 April (3 weeks);
      2021 - Pre-Exam 28 February results 31 March (4 weeks);
      2019 - Pre-Exam 24 February - results 12 March (3 weeks)

      Delete
  5. And thank you for the replies 😃

    ReplyDelete
  6. 8.2 Martha is not entitled to a reduction of the opposition fee.
    the question of entitlement does not arise , as there is no provision of reduction of opposition fee, so should be false/true.

    ReplyDelete
    Replies
    1. I donot understand. As there is no provision for a reduction, no one can be entitled for a reduction (and the EPO cannot give a reduction at free will). So answer is unambiguous.

      Delete
    2. So if you answer false, it means Martha is entitled to reduction?

      Delete
  7. In question 3.4, EP-AF2 is not claimoing priority from DE-AF, so wouldn´t DE-AF simply be seen as prior art, claiming priority to EP-AF2 may still be validly done, only DE-AF would destroy novelty of both EP-AF2 and EP-AF3?

    ReplyDelete
    Replies
    1. That is not asked. It is asked whether she can file a new appl that validly claims priority - not whether it would be novel.

      Delete
    2. I agree with you, since we don't claim the priority of DE-AF, it will be considered as a first application, which means that priority could be validly claimed.

      Delete
  8. DE-AF2 is not the first filing of the subject-matter, therefore priority cannot be validly claimed from it

    ReplyDelete
    Replies
    1. Please clarify, there is no DE-AF2 in the case…

      Delete
  9. Regarding q 3.3, isnt there the following requirement too? indication as to where the correct application documents or parts are completely contained in the earlier application and, where applicable, in the translation thereof? This requirement is not fulfilled therefor redate rather than original date kept?

    ReplyDelete
    Replies
    1. In Question 3, it is stated that "On 2 May 2023, Anna-Frieda filed the missing drawings for EP-AF1, together with a certified copy of DE-AF, a letter correctly stating that the missing drawings are identical to those of DE-AF and a request to maintain the filing date of 24 April 2023." While it does not use the exact wording of Rule 56(3), it looks clear to me that "identical drawings" refers to the "indication as to where the correct application documents or parts are completey contained in the ealier application ..." and togehter with the certified copy and the letter intends to provide all the requirements for Rule 56(3), and thus nu re-dating.

      Delete
    2. I agree with Johan. Also as no drawings were filed at all, it seems superfluous to ask where they are as it can me immediately recognized.

      Delete
  10. For 7.1, is it not the case that EP-M1-A1 will not form part of the state of the art against the subject-matter of claim 1 of EP-M2 under Article 54(3) EPC, because EP-M1-A1 is a publication disclosed after the filing date of EP-M2. The application as filed for EP-M1 may be considered 54(3) prior art, but not the publication EP-M1-A1.

    ReplyDelete
    Replies
    1. Thanks Tom, that what was precisely my reasoning as well. As the question specifically introduces EP-M1-A1 distinct from EP-M1, and then directs the question of prior art to EP-M1-A1, NOT EP-M1.

      Delete
    2. I think EP-M1-A1 is used in this question to emphasise that this EP application is validly published, which is a prerequisite of being a A.54(3) prior art. The decisive factor is still the comparison of the filing datas and the publication dates between the EP applications.

      Delete
    3. @Linda A54(3) prior art is "the content of European patent applications filed", not their posterior publications. It is therefore incorrect to consider EP-M1-A1 prior art instead of EP-M1 - this appears also confirmed by Roel hereabove, who only refers to EP-M1 in his answer, even though the question is directed to EP-M1-A1.

      In my view, if the statement was to be directed to the EP as filed (EP-M1), it would have sufficed to mention that it was validly published later; naming of EP-M1-A1

      Delete
    4. I added a Note to the answer 7.1 in the blog post to address this issue (see “Note (added 19/3 in view of discussions on the blog)”.

      Delete
  11. 9.1 Further processing for performing the requirements for entry into the EP regional phase can be validly requested on 19 June 2024.

    I put false on this one since I reasoned that "the" requirements would imply that this statement is applicable for "all" of the acts under rule 159. However, one cannot request for further processing for renewal fees, no?

    ReplyDelete
    Replies
    1. That is correct, and renewal is due under R.159(1) at entry in this case. It was missed, so just be remedied, but for that indeed you cannot use FP but need R.51(2). This could be a good reason to answer FALSE, if you interpret the statement as “were any acts missed and can you remedy all of these with FP”.

      There is however no deemed withdrawsl yet due to the missed renewal at its due date = entry date, as you can still pay it with additional fee and the loss only takes place at the end of the 6m period. This could be a reason to answer TRUE if you interpret the statement as “FP for all acts which led to a loss of rights”.

      We will need to see what the Committee had in mind, and whether the statement will be neutralized or not.

      Delete
    2. I also answered False to 9.1 exactly for the renewal reason

      Delete
    3. I also answered FALSE to this question for the renewal fees reason.

      Delete
  12. 8.3 If Martha requested in the notice of opposition to speak and listen in German during oral proceedings, the EPO would provide for interpretation.

    I was a bit confused about this. I do not necessarily disagree with your answer concerning this question; indeed, the answer ought to be correct should Martha request this well in advance, but there is nothing in the question that suggests that Martha would do so. I put false on this one since I was under the impression that this is not always true. In my opinion this question is worded ambiguously, but please correct me should I have misinterpreted the question.

    ReplyDelete
    Replies
    1. Since she requests it in the notice of opposition according to the question, it would automatically be well in advance of the oral proceedings. It would even be the earliest possible time for her to indicate it, so she can't be more well in advance than that.

      Delete
    2. @Johanna, I see. R115(1) states that the parties should be given at least 2 months' notice before the oral proceedings. Hence should Martha request this in the notice of opposition, then this would automatically be at least 2 months before the oral proceedings?

      I am considering a situation where she would be denied interpretation. Perhaps should Martha request oral proceedings in the notice of opposition but omit (or request it too late) the request to speak in German, then she would be denied interpretation?

      Delete
    3. Same situation was also in an earlier Pre-Exam: notice of opposition is far before summons, so the 1m surely met.

      Delete
    4. Same situation was also in an earlier Pre-Exam (2016, Q.10) -- refer to Compendium or to our P-book ""Pre-Exam - Cases/Exams" with updated versions:

      Question 10 (Pre-Exam 2016)
      On 28 February 2016, Paco, a Spanish national resident in Spain, filed with the EPO a
      reasoned notice of opposition against European patent EP-E in Spanish. The mention of
      the grant of EP-E was published on 3 June 2015. The language of the proceedings of
      EP-E is English. In the notice of opposition, Paco requested oral proceedings.

      For each of the statements 10.1 – 10.4, indicate on the answer sheet whether the
      statement is true or false:

      10.1 Paco is not entitled to a reduction of the opposition fee.
      10.2 Paco must file the translation of the notice of opposition at the latest on
      3 March 2016.
      10.3 If Paco requested in the notice of opposition to speak and listen in French during
      oral proceedings, the EPO would provide for interpretation.
      10.4 Paco will be allowed to speak Spanish during oral proceedings if he provides for
      interpretation into English.

      Examiner's Report 2016 w.r.t. Question 10:
      "Under the EPC, opponents are not entitled to a reduction of the opposition fee, see
      Rule 6(3) and (4) EPC. Natural persons having their residence within a Contracting State
      having a language other than English, French or German as an official language (such as
      Paco), may file documents which have to be filed within a time limit (in this case a notice of
      opposition) in an official language of that State (in this case Spanish) (Article 14(4) EPC).
      A translation must be filed within one month of filing the notice of opposition,
      Rule 6(2) EPC, that is on 29 March 2016 [28 February 2016 + 1 month (Rule 131(4) EPC)
      = 28 March 2016, extended to Tuesday, 29 March 2016 (Rule 134(1) EPC)]. Any party to
      oral proceedings before the EPO may use one of the other official languages of the EPO,
      on condition that such party gives notice to the EPO at least one month before the date
      laid down for such oral proceedings. Alternatively, the party may make provision for
      interpreting into the language of the proceedings, English, Rule 4(1) EPC.
      10.1 - True
      10.2 - False
      10.3 - True
      10.4 - True"

      Delete
    5. Thank you Roel, I studied the previous pre-exams quite thoroughly but still managed to answer this incorrectly...

      Delete
    6. Hi Peter, errors are easily made… due to overlook a legal provision, misread a GL section, overlook (the relevance of a) fact, an inaccuracy (e.g., we also had a T where we argued F (or vv) somewhere)…
      Luckily you can make quite some before you get to a fail: 15 isolated errors would score 70 marks (and if 3 or more on a single question, even some kore).

      Delete
  13. Thanks for getting this up so quickly! Looks like I got 44-48/50 (depending on what happens with the ambiguous questions)

    ReplyDelete
  14. Regarding 7.3, you view F because the conceptual Cu part benefits from partial priority and is thus not novelty destroyed. However the claim is merely "a fork made of metal". That is the subject matter of Cu is not specified. So taking a hardline approach, surely a claim merely to "metal" would not be entitled to priority, so the claim is invalid, so a publication of a Cu fork is novelty destroying, so the answer should be T? I would agree with you F is the claim was to "a fork made of metal, such as copper". There is some ambiguity because the Q doesn't provide the literal claim wording.

    ReplyDelete
    Replies
    1. That is still a conceptual or-claim with the parts "metal but not copper" and "copper", see G1/15. Cu is a metal so it is encompassed and therefore has partial priority.

      Delete
    2. Oh and partial priority seems a very important concept for the EQE - it came in two main exams this and last year. It's very important to understand it well since I assume the examining committee may continue testing it.

      Johanna

      Delete
    3. I spent most of the 70 minutes of part 2 on question 7.
      At first I thought it was a very clear case of partial priority. Then I changed all my answers.

      EP-M1 claims and discloses copper OR zinc.
      EP-M2 claims metal and discloses copper, zinc or iron or an ALLOY thereof.

      Since an alloy also means copper AND zinc, I concluded that this leads to an invalid priority claim and thus to the fact that PA-1 is novelty-destroying against both claim 1 and claim 2 of EP-M2.

      Delete
    4. Thanks for explaining this in more depth. Using that case law I also found F-VI 1.5, which helps further explain the concept. This is definitely something I do not yet appreciate fully so will study it in more depth. Thanks :-)

      Delete
    5. We discuss partial priority as well as many other priority aspects and other beyond-Pre-Exam level topics in detail in our online "D Distance" course that starts in the last week of May. It has 1 full day of D1 introduction, 7 afternoons of D1 legal topics (build on homework discussions and some interactive presentations), and 2 full days of D2 introduction/practice.

      Please refer to our website for details: https://www.deltapatents.com/cursus/d-distance-learning/

      Delete
  15. I think the 3.4 should be True because the ep-af2 has no priority. It is independent from german application. So, it is the first filling and ep-af3 can have validly claiming priority.

    ReplyDelete
    Replies
    1. DE-AF is clearly "first application" - see Guidelines F-VI 1.4

      Delete
    2. EP-AF2 is not the first application because it has same applicant with DE-AF? Because if other applicant than applicant of DE-AF independently file application (let's say EP-X) about same invention (after the DE-AF) and also claim priority for other application (let's say WO-X) from EP-X. Both EP-X and WO-X clearly has no novelty and no meaning to file such an application but there will be no objection about priority of WO-X. I'm confused even after I read F-VI 1.4 because EP-AF2 doesn't refer DE-AF in any part of procedings. (they don't even refer DE-AF when correcting claims)

      Delete
    3. Thanks for clarification, Thomas. I was sure about EP-AF1 isn't the first application but indication in the question that EP-AF2 has no legal connection (other than applicant) to DE-AF make me think that they are independent so i mark wrong answer.

      Delete
    4. &Anon: there is no need for a “legal connection” as you phrase it. There is also a classical first application issue in the case where: first, a national US1 is filed describing A, then an EP1 describing A, and then an EP2 that claims A and claims priority from EP1 but not from US1 - all filed by same applicant. In this case, the priority is not valid as US1 is the first application for A from this applicant and is thus the only possible valid priority application (both in case EP1 claims prio from US1 so they is also easily detected, as well as in case EPQ does not claim prio from US1) (Art.87(4) is of no help, as US is not EP).
      GL F-VI, 1.5 / T 282/12 clarifies that such a first application issue also arises if US1 would not have described the genus A but just a species A1: in that case, EP1 is not the first application for the conceptual part A1 of A (but it is for “A, but not A1”) so that EP2’s priority from EP2 is not valid for this conceptual part A1 of its claim A.
      (In this example, I used a US as the earliest in the sequence to prevent confusion - in the case at hand it was also an EP but that does not change the arguments as this EP was published so that Art.87(1) does not help here either).

      Delete
  16. Do not think about applicants. If there would be a different applicant, it would be a question about novelty and prior right.

    In this case all mentioned applications are filed by the same applicant and the statement is clearly about valid prio claim and nothing else.
    EP-AF2 is not the first application because it does not disclose first time the invention AF2. AF2 is disclosed first time in DE-AF, which makes DE-AF to the first application in regard to invention AF2.

    ReplyDelete
    Replies
    1. I agree. See also what the DBA said on interpretation and understanding of Pre-Exam questions in our blog post “On the interpretation of Pre-Exam Questions and on Pre-Exam appeals (Blog Post)” (see left column on this blog pages when using a computer, or at the bottom when using a mobile phone or direct link: https://pre-exam.blogspot.com/2022/02/on-interpretation-of-pre-exam-questions.html)

      Delete
  17. I think the answer to 1.3 should be false. They speak about a period for filing. It can be filed after the notification. In previous exams the used different wordings according to which it could be both false or true

    ReplyDelete
    Replies
    1. That is why our original blog post already said:

      “FALSE could also be argued in view of R.58 and D 3/19”.

      See our earlier blog post on D 3/19:
      https://pre-exam.blogspot.com/2020/07/d-319-term-must-in-statement-41-of-pre.html

      Note that the wording of the current statement 1.3 is different. When applying D 3/19, one could however argue that it has essentially the same system as there is a “period” in R.6(1) as well as in R.58. And, one of the key arguments by the DBA, the effect of missing the period is not mentioned (which would, if mentioned, have allowed to discriminate between the periods)

      Delete
  18. Reminder: Please do not post your comments anonymously - it is allowed, but it makes responding more difficult and rather clumsy ("Dear Mr/Mrs/Ms Anonymous of 06-03-2024 06:03"), whereas using your real name, your initial or a nickname is more personal, more interesting and makes a more attractive conversation. You do not need to log in, not make an account, nor give your email address; you can us post Comment As --> Name or URL: Give your name, nickname or your initials and use them consistently.

    ReplyDelete
  19. Hello Roel,

    regarding 7.1 where it is not clear if EP-M1-A1 forms part of the state of the art against the subject-matter of claim 1 of EP-M2.

    I argued that if the subject-matter of the part of the claim that does not benefit from priority was not novel, then the conclusion would be that claim 1 lacks novelty.

    Therefore, EP-M1-A1 must be part of the prior art against claim 1, otherwise such a conclusion cannot be made.

    If EP-M1-A1 would not be part of the prior art of claim 1, then claim 1 would be novel, even if part of this claim was not.

    I thus had to anwser true.

    Peter

    ReplyDelete
    Replies
    1. 7.1 does not ask about novelty (effect of it being prior art, if so). It just asks whether EP-M1-A1 is prior art or not ("status of EP-M1-A1").

      Distinguish definition of novelty in 54(1):
      Art. 54(1): An invention shall be considered to be new if it does not form part of the state of the art.
      vs definition of prior art in 54(2)&(3):
      Art. 54(2) The state of the art shall be held to comprise **everything** made available to the public by means of a written or oral description, by use, or in any other way, before the date of filing of the European patent application.
      Art. 54(3) Additionally, the content of European patent applications as filed, the dates of filing of which are prior to the date referred to in paragraph 2 and which were published on or after that date, shall be considered as comprised in the state of the art.
      The **everything** may include novelty-destroying prior art as well as non-relevant prior art (which usually is much more than the few novelty-destroying one; and which may also include one that are not prejudicial for novelty but is prejudicial to inventive step in combination with other prior art).

      Delete
  20. For question 6.2, I used the sentence "at an early stage in the examination procedure" which was in the explanation of the case.

    Now, the Applicant has not filed the request with the appeal.

    I concluded that since the request which was filed early in the Examination procudure, the Applicant has since had the opportunity to be heard, and there was no procedural violation with respect to Art 113.

    Therefore, I answered false.

    ReplyDelete
    Replies
    1. In addition to my above comments, I also took into account that the initial request was filed to the Examining devision, whereas no request has been filed to the board of appeal.

      The board of appeal has received no request for oral proceedings

      Delete
    2. Please disregard my comments on oral proceedings, they are wrong and I cannot delete them

      Peter

      Delete
  21. I disagree with 7.3.

    GL G VI 5 Generic disclosure and specific examples
    In considering novelty, it is to be borne in mind that a generic disclosure does not usually take away the novelty of any specific example falling within the terms of that disclosure, but that a specific disclosure does take away the novelty of a generic claim embracing that disclosure, e.g. a disclosure of copper takes away the novelty of metal as a generic concept, but not the novelty of any metal other than copper, and one of rivets takes away the novelty of fastening means as a generic concept, but not the novelty of any fastening other than rivets.

    Metal cannot be consideread equivalent as "Copper OR Metals that are not copper". It's just metals. The applicant will enjoy priority only if they limit the claims to copper.

    Accordingly on GL F VI 1.5 Multiple priorities and partial priorities
    merely states that

    For example, if the priority document discloses the use of a specific composition whereas the application claims the use of a composition defined in more generic terms, two alternative groups of subject-matters are identified as being encompassed by the claim, even if the claim does not expressly spell them out:


    alternative (a), concerning the use of a specific composition (e.g. calcium salt of the active ingredient and tribasic phosphate salt in which the cation was multivalent) and


    alternative (b), concerning the use of a composition defined in more generic terms (e.g. acid form or acceptable salt thereof as the active, inorganic salt in which the cation was multivalent, wherein active ingredient and inorganic salt were other than calcium salt of the acid and tribasic phosphate salt in combination).

    Alternative (a) is the subject-matter disclosed in the priority document, not defined as such in the claim but encompassed by it. Alternative (b) is the remaining subject-matter of the claim, which was not disclosed in the priority document. In such a situation, the subject-matter of alternative (a) enjoys priority whereas that of alternative (b) does not.

    The passage merely states that (a) enjoys the priority, i.e. you could limit the claims to that and be fine. The genus should be interepred as AND not OR.

    Metals is not Copper OR Metals that are not copper, but is Copper AND metals that are not copper. Thus it is not novel

    ReplyDelete
    Replies
    1. I also agree with this interpretation.

      After all you would write a claim like:
      wherein the metal is selected from the group consisting of: Copper, Iron, .. AND Zinc.

      You don't write a claims like:
      wherein the metal is selected from the group consisting of: Copper, Iron, .. OR Zinc.

      Delete
    2. I also similar interpretation regarding question 7

      Delete
    3. Same. And even in we considered that Copper had partial priority it still would be false. A fork made of copper takes out the novelty of a fork made of bronze or any other alloy of copper

      Delete
    4. It may be worth to read G 1/15 to understand the Guidelines section (which cites just the headnote and one of its reasons): if the prio has Cu, and the subseq has metal, then the claim is to be considered as a “generic OR claim”, which is an OR of two conceptual parts: “Cu” OR “metal but not Cu” (also if there would not be basis to amend in the subsequent application to this OR - that is why they name it “conceptual part”s).

      Delete
    5. So that the conceptual “Cu” part has priorty and is not novelty-destroyed by a Cu-disclosure in the priority interval, while the conceptual “metal but not Cu” part has no priority and may, e.g, be novelty-destroyed by a disclosure any specific other metal, e.g. Al, in the priority interval. Similar for, e.g., narrow prio range and broader subsequent range.

      Delete
    6. I disagree. You are ignoring the fact that I could devide the group "metal but not Cu" in "metal but not CU, wherein the metal comprises CU" OR "metal but not CU, wherein the metal does not comprises CU". The prior publication is clearly novelty destroying for "metal but not CU, wherein the metal does not comprises CU"

      Delete
    7. @Roger: I do not agree that “metal does not comprise Cu” is directly and unambiguously disclosed in the prior art publication - which is necessary to be novelty destroying when following your argumentation.

      Also, case law following G 1/15 is very explicit that a partial priority can by definition not be novelty-destroying, as the part with priority is not prior art (same date) and the part without does not comprise the partial priority disclosure. So, your argument must fail in view of that.

      Note: the first statement does **not** ask about a novelty conclusion, it justs asks about the status: 54(3) or not.

      Delete
    8. I meant: "“metal that do comprise Cu".

      PA discloses: A fork made of Copper. A fork made of a Metal, which comprises Copper, and "A fork made of a Metal".

      The partial priority applies only to: "A fork made of Copper" but not to "A fork made of a metal, which comprises Copper", i.e. you would not be able to extend partial priority to a fork made of Bronze, which is a "A fork made of a metal, which comprises Copper".

      Thus, in view of PA, the group "A fork made of a metal, which comprises Copper" is not novel, thus necessarily also: "A fork made of metal" is not novel.

      Delete
    9. I believe that the question, by consistently using "made of" for all the disclosures and by separately listing copper and alloys in EP2, is indicating that copper and its alloys are to qualify as different materials. So, "a fork made of copper" would not offer priority for "a fork made of metal [copper alloy]" (EP1 vs. EP2), but, when disclosed in PA1, would also not anticipate "a fork made of copper alloys" in EP2. Conversely, if "a fork made of copper" of PA1 is considered as anticipating "a fork made of metal [copper alloy]", then "the fork made of copper" of EP1 should offer adequate priority for "a fork made of metal [copper alloy]"

      "EP-M1 disclosing and claiming a fork made of copper or zinc"

      "EP-M2 claiming priority from EP-M1 and disclosing and claiming a fork made of metal. The description of EP-M2 mentions that the metal can be copper, zinc, iron or any alloy of these metals."

      "A company brochure PA-1 published on 5 October 2021 discloses a fork made of copper with a hollow handle"

      Delete
    10. @GB: So, "a fork made of copper" would not offer priority for the complete claim to "a fork made of metal". But "a fork made of copper" does give (partial) priority for the conceptual part "a fork made of copper" of the "a fork made of metal" claim - where the latter claim can be considered as an OR claim ("generic OR claim"): "a fork made of copper" OR "a fork made of metal where the metal is not copper". That is exactly what G 1/15 has explained to be the partial priority concept. See T 2387/13 (cited below) for example that applied G 1/15.

      G 1/15 made an end to the (debated) "poisonous divisional" and "poisonous priority" lines of case law which argued "Cu is not the same as metal, so there is no priority at all, so the Cu priority kills novelty of the subsequent metal". G 1/15 clarified that that reasoning is incorrect, and that, rather, the Cu in the priority gives a partial priority to the later metal claim, meaning that neither the Cu in the priority itself nor a Cu disclosure in the priority interval kills the novelty of the later metal claim. It is not even necessary that the later application mentions Cu: it is sufficient that the priority disclosure is "encompassed" by the later claim, i.e., that there is a species-genus relation.

      If there are still unclarities about partial priority (species in prio, genus in subsequent appl): read the full decision G 1/15 and decisions citing that, e.g., T 2387/13. And forget about poisonous priorities and poisonous divisions, as they do not exist and were just a ripple in history.
      Also T 282/12 (also cited in GL F-VI, 1.5) is worth reading, which explains that the partial priority concept also has to be considered when assessing whether a priority is the first application for some broad subject-matter or whether there is maybe an earlier application with more specific subject-matter encompassed by that broad subject-matter so that the priority is not the first application for the full broad subject-matter, as it is not the first application for its conceptual part corresponding to the specific subject-matter -- this was tested in the D as well as the C paper this year!

      Delete
    11. Hi Roel, thanks for your reply. Indeed, I agree with what you stated above, my comment was trying to address the point in the comments above as to the disclosure/anticipation of forks "comprising" (rather than "made of") copper. Because the terminology adopted "made of" is the same in all applications and in the brochure, whatever is considered that PA1 discloses must be considered disclosed also for EP1 (so, with respect to the material of the fork - not the handle, of course - EP1 and PA1 have identical disclosures).

      BTW, from the point you made above about G1/15, I also wonder whether the question of A54(3) prior art status for EP1 was aimed (with a not-so-happy phrasing) at testing precisely that concept: A priority application cannot be "poisonous"; so, while it may be an interesting debate as to whether a priority application should be considered A54(3) prior art for the part of the claim not entitled to priority, in practice such A54(3) status has never consequences for the patentability of the claim.

      Delete
    12. Hi GB, see my comment below “Roel van Woudenberg 20 March 2024 at 11:26” in response to another comment:
      Due to the partial priority situation, it **is** 54(3) for the ( conceptual) part without priority, but it is **not 54(3)** for the (conceptual) part with priority.

      Delete
  22. Yes, even if there are 2 conceptual parts to the claim - one is directed to Cu or Zn, the other one is directed to metals other than Cu or Zn, the second conceptual part is still considered a genus claim directed to many types of metals other than Cu or Zn (not specific types of metals). I think I believe that a prior art that discloses fork made of Cu (species) takes away the novelty of the 2nd conceptual part directed to metals other than Cu or Zn (genus).

    ReplyDelete
    Replies
    1. "Cu" is indeed within the more generic terms "metal" and would be novelty destroying to "metal" if/as far as that has a later date. However, it has to be compared to the OR of two conceptual parts, one with priority ("Cu or Zn") and one without ("metal but not Cu nor Zn". As it has priority for "Cu", "Cu" is not prior art to the conceptual "Cu"-part. But "Cu" is not within the terms of "metal but not Cu nor Zn", so the 2nd conceptual part is novel w.r.t. "Cu" (it would possibly not be inventive, but that is not asked).

      By the way, we were very surprised that partial priority was tested in the Pre-Exam, which is supposed to test the EQE syllabus at a level one can reasonably expect from a trainee patent attorney after 2 years of supervised work. We do discuss it in our Pre-Exam courses, because it is a too nice topics to ignore as it shows very well how priority works as to the "same invention" criterium: it works forward in time from the priority application rather than backward in time from the subsequent application (only relevant as far as there is a relation between them - the "encompassed" in the headnote of G 1/15) and it serves as a shield against otherwise novelty-destroying disclosures of the same subject-matter (as in the priority). "It you understand the same invention test of partial priority, you understand same invention as expert level", is what I use to add.... but now I would need to add "and you need this expert level already at the Pre-Exam stage". Will it also be needed for the Foundation Paper, as it is in the Guidelines - I hope not, this will be too difficult when you are in your first year in the profession and prepare for the Foundation at the first opportunity.

      Delete
  23. Thanks for posting the above suggested answers. Concerning question 5.3; I still have some doubt and would have considered the answer to be potentially false. While according to R81 2nd sentence, the OD may use grounds for opposition not invoked by the opponent of its own motion if prima facie relevant; a further condition is that the opposition must be admissible according to Art 101. Based on the information we have, this is not the case in the present case as the opposition fees have not been paid.
    While the English version states "may examine EP-R for sufficiency of disclosure"; the French version states "peut examiner", which does not have the exact same meaning...

    ReplyDelete
    Replies
    1. The own motion only applies as far as in the extent - G 10/91 and G 9/91

      Delete
    2. I agree with Juliette here and strongly believe 5.3 to be FALSE.

      5.3 unambiguously must relate to the situation presented in the main question above.
      Here, as the fees have not (yet) been paid, the notice of opposition is deemed not filed and would still be disregarded as a whole by the formalities officer, thus the opposition was never opened nor pending.
      The Opposition Division is not entitled to examine anything at this point as no opposition is pending.

      At this point, without the payment of the fees, the only informations to consider are that the patent has been granted by the EPO. The EPO thus cannot examine any grounds, be it grounds of an opponent or of its own motion.
      As for the notice of opposition filed (yet deemed not received) the grounds/arguments will only be added to the file as regular third party observations (D-IV, 1.4.1) while no further examination (or opposition proceedings) may be carried on.
      The cases where the OD can move on, of its own motion, are based on an opposition being duly filed first and the OD being made competent (for example an opposition filed, or withdrawn but filed in the first place).

      Delete
    3. I agree that the answer would need to be: TRUE if the opponent pays the opposition fee in time, i.e., today (see 5.1), but FALSE if the opponent does not pay the opposition fee by today as there will not be any pending opposition proceedings and the EPO/OD cannot start those by their own motion - but, as it is not given whether the opponent will or not, the statement cannot be unambigously answered as T or F...

      When answering this statement, one may have been biased by the sequence of the statement as presented to you (and they are randomized between candidates). Hence, if 5.3 would be presented first, you may be biased to "no fee paid" and concluded FALSE. Whereas if 5.3 was presented after 5.1 (as in the version we used), you may be biased to "fee can and will be paid today" and concluded FALSE. So, the randomizing of the statements may also have resulted in unequal situations for different candidates.

      Delete
    4. The Examiner's Report is out: statement 5.3 was not neutralized and the Examiner's Report makes no mention of the (non-)payment of the opposition fee or the (non-) existence of opposition proceedings. It seems that it assumes that the opposition fee will be paid so that opposition proceedings will become pending, so that EPO can introduce new grounds by own motion in those proceedings.

      Delete
  24. After reading the debate on 7.3 I have independently asked to several senior EPAs. None of them believes that partial priority applies here, and that it is just a genus-species question

    ReplyDelete
    Replies
    1. Why not? Please present your argumentation so that we can understand why.

      Delete
    2. Yes. PA discloses both species and genus. Partial priority only deals on which species within the genus enjoy priority, and which do not. Accordingly, G1/15 only deals with the priority of the species and never of the genus.

      If you do not agree with this interpretation. Could you please cite here the explicit passage in the G decision which supports your interpretation that partial priority extends to the genus?

      Delete
    3. The "genus but not species" part has no priority.
      But is not novelty destroyed by the species.

      Delete
    4. Also see T 2387/13, which was one of the early decisions applying G 1/15, reason 2.1.1:

      "International patent application D1 was filed on the same day as the international application on which the opposed patent is based and which is hereafter referred to as D0. Both applications claim the priority of Danish application D1a of 22 December 2006, the content of which is identical to the content of document D1. [...]

      Under these circumstances, **regardless of the precise contents** of the various applications [esp. D1] under consideration, **document D1 cannot destroy the novelty** of claim 1, for the following reasons:

      Generally speaking, claim 1 may encompass both subject-matter that is disclosed in document D1a (and, therefore, also in document D1) and subject-matter that is not. Subject-matter covered by claim 1 that is disclosed in document D1a will be referred to as part "A", and subject-matter covered by claim 1 that is not disclosed in document D1a will be referred to as part "B". Depending on the actual contents of claim 1 and document D1a, either part A or part B may be empty, **but the present argument is valid irrespective of those content**. **In any case, the sum of parts A and B forms the subject-matter of claim 1 of the patent. Claim 1 could therefore be rewritten as "A or B"**.

      As the alternative is not explicit, claim 1 may be understood to constitute a "generic 'OR' claim" within the meaning of the decision G 1/15 of the Enlarged Board of Appeal (published in OJ EPO 2017, A82), i.e. "a claim encompassing alternative subject-matter by virtue of one or more generic expressions or otherwise".

      According to decision G 1/15, part A cannot be refused the partial priority offered by priority document D1a. **As a consequence, document D1 is not part of the state of the art within the meaning of Article 54(3) EPC for part A**. Part B only benefits from the priority of application D0a. Consequently, **document D1 is state of the art within the meaning of Article 54(3) EPC for part B**. As a consequence, document D1 [or D1a] can only be used for the assessment of novelty, and cannot be considered when deciding whether there has been an inventive step within the meaning of Article 56 EPC. As document D1 [or D1a] **does not disclose** the subject-matter of part B (**by definition; otherwise this subject-matter would be part of part A and not of part B**), document D1 [or D1a] cannot destroy the novelty of claim 1."

      (Unfortunately, I cannot use colors, boldface or italics in these comments, so I treid to highlight sentences between double *'s).

      Delete
    5. Thanks for the long explanation. However I still not finding conving to argue that the same can be applied here. The T decision you cite refers to two applications which claim priority for the same document (!!). Thus, necessarily, any subject matter derived therefrom has the same effective date.

      According to case law, priority should be interpreted in a sense of a strict 123(2) interpretation. This means that the Priority EP2 only enjoys priority from EP1 regarding pure copper or pure zinc.

      The same limitation does not apply to a completly independent (!!) document in the prior art. The disclosure of Copper takes away the novelty of Metal, as well as the novelty of Metals comprising copper.

      Now, EP2 claim 1 can be divided in
      - a) pure copper or pure zinc, which enjoys priority from EP1; OR
      - b) not pure copper or not pure zinc, which has an effective date of EP2

      The problem here is that Copper takes away the novelty of b) because b include metals that comprise copper, but are not pure copper. You cannot ignore that Copper is present in both a) and b)

      Delete
    6. Just to add on the above. The problem of "Poisonous divisionals" also arises from the fact that the same document would otherwise end up conferring different effective dates to patents derived from the same(!!) document.

      The G and T decision do not discuss the scenario of two independent disclosure, and thus there is no basis for which it can just assumed that it can be extended to it (in my opinion)

      Delete
    7. “According to case law, priority should be interpreted in a sense of a strict 123(2) interpretation” is not quite correct: the case law says that you eed the same discloses test both: what is disclosed in the priority doc resp application as filed is using the same test (now referred to as the “gold standard”). G 1/15 made that most clear and made an end to the so-called “poisonous divisonals” and “poisonous priorities”.

      Delete
    8. See also, e.g., D2 2019 and Q.5 of D1 2022

      Delete
    9. The Examiner's Report (published today) gives the partial priority arguments (for details, see above) for 7.3 as:

      "7.3 PA-1 is novelty-destroying for the subject-matter of claim 1 of EP-M2 under Article 54(2) EPC.

      FALSE – G1/15, GL F-VI, 1.5 claim 1 enjoys partial priority in respect of copper and zinc,
      PA-1 is not prior art since it was published after EP-M2 filing date."

      Delete
  25. Regarding question 2.4 (Sabrina filing opposition for not being named as inventor), I interpreted the German wording "Einspruch einlegen" (eng: file an opposition) more broadly and came, based on Rule 20 (2), to the conclusion that she may file an opposition (of some kind) "mit der Begründung" (eng.: based on the ground) to be named as inventor... So I apparently understood the wording in a broader way :(

    ReplyDelete
    Replies
    1. But not being named as an inventor / I correct designation of inventor cannot be used as a ground of opposition - explicit in GL D-III, V.

      Delete
  26. The Examiner's Report for Pre-Exam 2024 has just been published (Compendium)!

    Six (!) individual statements were neutralized, of which one (1) on the legal part (statement 7.1 in our version).

    See https://pre-exam.blogspot.com/2024/04/pre-exam-2024-examiners-reprt-is-out.html

    I have added the reasoning given in the Examiner's Report for the neutralizations in the blog posts with our answers to the legal parts and in that with our answers to the claims parts.

    ReplyDelete
  27. The Examiner's Report provides:

    "10.4 If Wolfgang moves to Berlin two months after validly filing PCT-WC, the **International Bureau** will, upon request, record the change of residence in relation to PCT-WC.
    TRUE – Only the IB can record the residence change upon the applicant’s request, Rule
    92bis.1.(a) (i)PCT"

    Herein, the word "Only" is irrelevant for the current statement.
    The presence if the word "Only" can be explained from the reuse of this question, while the statement was amended to replace "EPO" (in both earlier uses of this question) by "IB".
    When the statement says "EPO", the "Only" is a very relevant element of the argumentation supporting FALSE. See e.g., the Examiner's Report of last year:
    "3.2 If, two months after validly filing PCT-SE, Saïd moves to Paris, the **EPO** will, upon request, record the change of residence in relation to PCT-SE.
    FALSE: Only the IB can record the residence change upon the applicant’s request, Rule 92bis.1.(a)(i)PCT"

    ReplyDelete

Post a Comment